How much funding has SurgAR raised?

SurgAR has raised $17.0M in total funding, most recently a Series A round.

Who are SurgAR's investors?

SurgAR's investors include Elaia.

Where is SurgAR headquartered?

SurgAR is headquartered in Clermont-Ferrand, France.

What industry is SurgAR in?

SurgAR operates in Artificial Intelligence, Healthcare.

SurgAR

Saving lives through better surgery!

Clermont-Ferrand, France · Founded 2019 · $17.0M raised

Artificial Intelligence

Healthcare

Headquarters: Clermont-Ferrand
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: surgar-surgery.com
Total Funding: $17.0M
Last Round: $15.0M Series AJan 2021
Rounds: 2

About

SURGAR is a French medtech company founded in 2019 that develops AI-powered augmented reality software for minimally invasive surgery, specifically targeting laparoscopic procedures involving mobile and deformable organs such as the uterus and kidney. The platform overlays reconstructed internal anatomical structures onto real-time laparoscopic video feeds, enabling surgeons to visualize what lies beneath the surface during procedures. SURGAR's technology serves hospitals and surgical centers primarily in gynecological, urological, and digestive surgery, and received its CE Mark for uterine applications in 2025.

Summary

SurgAR is an Artificial Intelligence company based in Clermont-Ferrand, France, founded in 2019. It has raised $17.0M in total across 2 rounds, most recently a $15.0M Series A round in Jan 2021. Investors include Elaia.